Subscribe

Criterion of Yatscoff et al for Discontinuation of Desferoxamine Therapy for Acute Iron Poisoning

Specialty:

Clinical Pharmacology & Toxicology
Emergency Medicine & Critical Care
Emergency Medicine & Critical Care

Objective:

ICD-10:

Description:

Yatscoff et al monitored the urine excretion of iron during therapy with desferoxamine. The ratio of urinary iron to creatinine can help determine when the chelation therapy can be discontinued.

To read more or access our algorithms and calculators, please log in or register.

RECENT TWEETS

medal descover
medal iphone